COVID-19 Booster Increases Antibody Response in Patients Receiving Active Cancer Treatment

Patients undergoing cancer treatment benefit from three doses of a COVID-19 vaccine (Pfizer, BioNTech). Study results showed that among 36 patients who experienced a weak humoral response after two vaccine doses, 27 exhibited a strengthened serologic response following receipt of a third dose.

Via JAMA Oncology. Published online January 7, 2022.

Specialties